Chlorhexidine hexametaphosphate nanoparticles as a novel antimicrobial coating for dental implants

Journal of Materials Science: Materials in Medicine

Volumn 26, Issue 6, 2015, Pages

  Wood, Natalie J ^a   Jenkinson, Howard F ^a   Davis, Sean A ^a   Mann, Stephen ^a   O’Sullivan, Dominic J ^a   Barbour, Michele E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; COATINGS; DEIONIZED WATER; MICROORGANISMS; NANOPARTICLES; TITANIUM; TITANIUM DEPOSITS;

ANTIMICROBIAL COATINGS; HEXAMETAPHOSPHATE; IMPLANT FAILURES; NANOPARTICLE (NPS); SALIVARY PELLICLE; STREPTOCOCCUS GORDONII; SUSTAINED RELEASE; TITANIUM SUBSTRATES;

DENTAL PROSTHESES;

CHLORHEXIDINE; CHLORINE; HEXAMETAPHOSPHATE SODIUM; NANOPARTICLE; PHOSPHORUS; TITANIUM; WATER; ANTIINFECTIVE AGENT; BIOCOMPATIBLE COATED MATERIAL; HEXAMETAPHOSPHATE; PHOSPHATE; TOOTH IMPLANT;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENTAL PELLICLE; DRUG SYNTHESIS; ELUTION; HUMAN; IMAGING; IMMERSION; MATERIAL COATING; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; STREPTOCOCCUS GORDONII; SUSTAINED DRUG RELEASE; TOOTH IMPLANT; ADVERSE EFFECTS; BACTERIAL LOAD; BACTERIUM ADHERENCE; CHEMISTRY; DRUG EFFECTS; IN VITRO STUDY; MATERIALS TESTING; MICROBIOLOGY; PHYSIOLOGY; SURFACE PROPERTY;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS GORDONII;

ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BACTERIAL LOAD; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; DENTAL IMPLANTS; HUMANS; IN VITRO TECHNIQUES; MATERIALS TESTING; NANOPARTICLES; PHOSPHATES; STREPTOCOCCUS GORDONII; SURFACE PROPERTIES; TITANIUM;

EID: 84933515598     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-015-5532-1     Document Type: Article

References (29)

1. Le Guehennec L, Soueidan A, Layrolle P, Amouriq Y. Surface treatments of titanium dental implants for rapid osseointegration. Dent Mater. 2007;23:844–54.
2. Almaguer-Flores A, Ximenez-Fyvie LA, Rodil SE. Oral bacterial adhesion on amorphous carbon and titanium films: effect of surface roughness and culture media. J Biomed Mater Res B Appl Biomater. 2010;92:196–204. doi:10.1002/jbm.b.31506.
3. Burgers R, Gerlach T, Hahnel S, Schwarz F, Handel G, Gosau M. In vivo and in vitro biofilm formation on two different titanium implant surfaces. Clin Oral Implant Res. 2010;21:156–64. doi:10.1111/j.1600-0501.2009.01815.x.
4. Frojd V, Chavez de Paz L, Andersson M, Wennerberg A, Davies JR, Svensater G. In situ analysis of multispecies biofilm formation on customized titanium surfaces. Mol Oral Microbiol. 2011;26:241–52. doi:10.1111/j.2041-1014.2011.00610.x.
5. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. 1. Success criteria and epidemiology. Eur J Oral Sci. 1998;106:527–51.
6. Lindhe J, Meyle J, Group DoEWoP. Peri-implant diseases: consensus. Report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35:282–5. doi:10.1111/j.1600-051X.2008.01283.x.
7. Renvert S, Polyzois I, Persson GR. Treatment modalities for peri-implant mucositis and peri-implantitis. Am J Dent. 2013;26:313–8.
8. Siqueira WL, Custodio W, McDonald EE. New insights into the composition and functions of the acquired enamel pellicle. J Dent Res. 2012;91:1110–8. doi:10.1177/0022034512462578.
9. Subramani K, Jung RE, Molenberg A, Hammerle CH. Biofilm on dental implants: a review of the literature. Int J Oral Maxillofac Implant. 2009;24:616–26.
10. Hultin M, Gustafsson A, Hallstrom H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implant Res. 2002;13:349–58.
11. Heuer W, Kettenring A, Stumpp SN, Eberhard J, Gellermann E, Winkel A, et al. Metagenomic analysis of the peri-implant and periodontal microflora in patients with clinical signs of gingivitis or mucositis. Clin Oral Investig. 2012;16:843–50. doi:10.1007/s00784-011-0561-8.
12. Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46:274–81. doi:10.1086/524736.
13. Barbour ME, Gandhi N, el-Turki A, O’Sullivan DJ, Jagger DC. Differential adhesion of Streptococcus gordonii to anatase and rutile titanium dioxide surfaces with and without functionalization with chlorhexidine. J Biomed Mater Res A. 2009;90:993–8.
14. Barbour ME, O’Sullivan DJ, Jagger DC. Chlorhexidine adsorption to anatase and rutile titanium dioxide. Colloid Surface A. 2007;307:116–20.
15. Saidin S, Chevallier P, Abdul Kadir MR, Hermawan H, Mantovani D. Polydopamine as an intermediate layer for silver and hydroxyapatite immobilisation on metallic biomaterials surface. Mater Sci Eng C, Mater Biol Appl. 2013;33:4715–24. doi:10.1016/j.msec.2013.07.026.
16. Wang H, Cheng M, Hu J, Wang C, Xu S, Han CC. Preparation and optimization of silver nanoparticles embedded electrospun membrane for implant associated infections prevention. ACS Appl Mater Interfaces. 2013;5:11014–21. doi:10.1021/am403250t.
17. Xie CM, Lu X, Wang KF, Meng FZ, Jiang O, Zhang HP, et al. Silver nanoparticles and growth factors incorporated hydroxyapatite coatings on metallic implant surfaces for enhancement of osteoinductivity and antibacterial properties. ACS Appl Mater Interface. 2014;. doi:10.1021/am501428e.
18. Martinez A, Guitian F, Lopez-Piriz R, Bartolome JF, Cabal B, Esteban-Tejeda L, et al. Bone loss at implant with titanium abutments coated by soda lime glass containing silver nanoparticles: a histological study in the dog. PLoS One. 2014;9:e86926. doi:10.1371/journal.pone.0086926.
19. Qureshi AT, Landry JP, Dasa V, Janes M, Hayes DJ. Can a novel silver nano coating reduce infections and maintain cell viability in vitro? J Biomater Appl. 2014;28:1028–38. doi:10.1177/0885328213491793.
20. De Giglio E, Cafagna D, Cometa S, Allegretta A, Pedico A, Giannossa LC, et al. An innovative, easily fabricated, silver nanoparticle-based titanium implant coating: development and analytical characterization. Anal Bioanal Chem. 2012;. doi:10.1007/s00216-012-6293-z.
21. Pauksch L, Hartmann S, Rohnke M, Szalay G, Alt V, Schnettler R, et al. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater. 2014;10:439–49. doi:10.1016/j.actbio.2013.09.037.
22. Barbour ME, Maddocks SE, Wood NJ, Collins AM. Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products. Int J Nanomed. 2013;8:3507–19. doi:10.2147/IJN.S50140.
23. Wood NJ, Maddocks SE, Grady HJ, Collins AM, Barbour ME. Functionalisation of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles. Int J Nanomed. 2014;9:4145–52.
24. Cortizo MC, Oberti TG, Cortizo MS, Cortizo AM, Fernandez Lorenzo de Mele MA. Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: evaluation of cytotoxicity and early bacterial adhesion. J Dent. 2012;40:329–37. doi:10.1016/j.jdent.2012.01.008.
25. Verraedt E, Pendela M, Adams E, Hoogmartens J, Martens JA. Controlled release of chlorhexidine from amorphous microporous silica. J Control Release. 2010;142:47–52. doi:10.1016/j.jconrel.2009.09.022.
26. Hannig C, Becker K, Hausler N, Hoth-Hannig W, Attin T, Hannig M. Protective effect of the in situ pellicle on dentin erosion—an ex vivo pilot study. Arch Oral Biol. 2007;52:444–9. doi:10.1016/j.archoralbio.2006.10.015.
27. Bressan E, Tessarolo F, Sbricoli L, Caola I, Nollo G, Di Fiore A. Effect of chlorhexidine in preventing plaque biofilm on healing abutment: a crossover controlled study. Implant Dent. 2014;23:64–8. doi:10.1097/ID.0000000000000018.
28. Machtei EE, Frankenthal S, Levi G, Elimelech R, Shoshani E, Rosenfeld O, et al. Treatment of peri-implantitis using multiple applications of chlorhexidine chips: a double-blind, randomized multi-centre clinical trial. J Clin Periodontol. 2012;39:1198–205. doi:10.1111/jcpe.12006.
29. De Siena F, Francetti L, Corbella S, Taschieri S, Del Fabbro M. Topical application of 1% chlorhexidine gel versus 0.2% mouthwash in the treatment of peri-implant mucositis. An observational study. Int J Dent Hyg. 2013;11:41–7. doi:10.1111/idh.12002.